Market Access News | pharmaphorum

News

Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them.

News

Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.

News

COVID-19 vaccine mandate critic Vinay Prasad has been named as director of the FDA's Center for Biologics Evaluation and Research (CBER).

News

The Trump administration has intervened in a long-running lawsuit over the abortion pill mifepristone.

News

More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi has been given the go-ahead by the agency.

News

Shares in Eli Lilly have weakened after pharmacy benefit manager CVS Health said it would no longer cover its weight-loss therapy Zepbound.